Skip to content
Peter Attia MDPeter Attia MD

303-A breakthrough in Alzheimer’s disease: potential of klotho for brain health & as a therapeutic

View show notes here: https://bit.ly/4bwwZVe Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Dena Dubal is a physician-scientist and professor of neurology at UCSF whose work focuses on mechanisms of longevity and brain resilience. In this episode, Dena delves into the intricacies of the longevity factor klotho: its formation and distribution in the body, the factors such as stress and exercise that impact its levels, and its profound impact on cognitive function and overall brain health. Dena shares insights from exciting research in animal models showing the potential of klotho in treating neurodegenerative diseases as well as its broader implications for organ health and disease prevention. She concludes with an optimistic outlook for future research in humans and the potential of klotho for the prevention and treatment of Alzheimer’s disease. Disclosure: Peter is an investor in Jocasta Neuroscience, a company working to develop klotho as a therapy for people with Alzheimer’s disease. We discuss: 0:00:00 - Intro 0:01:19 - Dena’s fascination with aging and how she came to study klotho 0:11:00 - Biological properties of klotho: production, regulation, decline with age, and factors influencing its levels 0:23:08 - Potential benefits of klotho on brain health 0:36:18 - The relationship between soluble klotho protein, platelet factors, and cognitive enhancement 0:52:31 - The role of platelet factor 4 (PF4) and it’s interaction with GluN2B in mediating cognitive enhancement 1:02:52 - Benefits of klotho observed in a mouse model of Parkinson’s disease 1:11:22 - Benefits of klotho observed in a mouse model of Alzheimer’s disease 1:17:18 - Promising results of klotho in primate models, and the importance of finding an appropriate therapeutic dose before moving to human trials 1:39:34 - Speculating why a single klotho injection has such long-lasting effects 1:42:45 - Potential cognitive benefits of klotho in humans, the impact of the KL-VS genetic variant on klotho levels, and the need for human trials to confirm these effects 1:50:10 - The interaction between the KL-VS genetic variant and APOE4 and how it impacts risk of Alzheimer’s disease 2:05:26 - The significance of klotho levels: studies linking lower levels to increased mortality and the broader implications for organ health and disease prevention 2:11:48 - Measuring klotho levels and determining an individual’s KL-VS status 2:18:32 - The promising potential of klotho for Alzheimer’s disease treatment, and the importance of philanthropy for funding research -------- About: The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more. Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. Learn more: https://peterattiamd.com Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

Dena DubalguestPeter Attiahost
May 27, 20242h 23mWatch on YouTube ↗

At a glance

WHAT IT’S REALLY ABOUT

Klotho Hormone Enhances Cognition and May Protect Against Alzheimer's, Says Dubal

  1. Klotho was discovered by accident in 1997 when mice with a disrupted gene aged prematurely, while overexpression extended lifespan by about 30%.
  2. In mice, klotho overexpression or injection enhanced cognition, and in Alzheimer's model mice it normalized cognition and preserved synapses even though amyloid and tau remained, which Dubal describes as resilience.
  3. A single low, physiologic dose enhanced cognition in aging monkeys within four hours for at least three weeks, while much higher doses gave no benefit, pointing to a therapeutic window.
  4. Klotho does not cross the blood-brain barrier, and the mechanism of its effect remains partly unknown, though platelet factor 4 acting through GluN2B is sufficient but not necessary.
  5. Human genetics (the KL-VS variant) and epidemiology link higher klotho to better cognition, blunting of APOE4 risk, and lower mortality, but human trials and a standardized assay are still needed.

IDEAS WORTH REMEMBERING

5 ideas

Klotho levels fall with age but can be influenced

Dubal says levels are about six times higher at birth and can drop by half from age 40 onward; chronic stress is linked to lower levels, while chronic exercise raised them about 30% in studies.

Klotho acts without entering the brain

Peripheral klotho does not cross the blood-brain barrier, yet an injection boosts cognition within four hours; it activates platelets to release PF4, which does reach the brain and works through GluN2B.

PF4 is not the only messenger

Klotho still enhanced cognition in mice lacking PF4, so PF4 is sufficient but not necessary, and Dubal's lab is searching for other factors.

Klotho provides resilience rather than removing pathology

In Alzheimer's model mice with elevated klotho, amyloid and tau levels were unchanged but cognition and synapses were preserved, which Dubal likens to a helmet for neurons.

More klotho is not better in primates

In monkeys a physiologic dose improved working and spatial memory for at least three weeks, while doses roughly ten to twenty times higher did not help, unlike in mice.

WORDS WORTH SAVING

5 quotes

We need cocktails that can really resist multiple protein toxicities.

— Dena Dubal

In other words, their brains are still riddled with the Alzheimer's toxins, but they've been able to really thwart the effects of those toxins because they show normal cognition.

— Dena Dubal

The job is knowledge creation for the purpose of making lives better.

— Peter Attia

I mean, who would have, who would have thought that platelets could be messengers of brain health

— Dena Dubal

I don't wanna spend my career on something that's not important. If it's done well, we'll know.

— Dena Dubal

Klotho discovery and biologyDecline of klotho with age, stress, and exercisePlatelet factor 4 and GluN2B mechanismMouse models of Alzheimer's and Parkinson'sMonkey study and dosing windowKL-VS variant and APOE4 interactionKlotho measurement and organ health

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.

iOSAndroidClaudeChromeChatGPTComing soon